ArticleScientific reports2025

SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation.

Liangying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.